Literature DB >> 8132843

Cytotoxic activity of Helicobacter pylori enhanced by acetohydroxamic acid.

H von Wulffen, T Marquardt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8132843      PMCID： PMC501847          DOI： 10.1136/jcp.47.2.188-b

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  7 in total

1.  Helicobacter pylori acid resistance.

Authors:  C Mooney; D J Munster; P F Bagshaw; R A Allardyce
Journal:  Lancet       Date:  1990-05-19       Impact factor: 79.321

2.  Antibacterial action of the urease inhibitor acetohydroxamic acid on Helicobacter pylori.

Authors:  K Phillips; D J Munster; R A Allardyce; P F Bagshaw
Journal:  J Clin Pathol       Date:  1993-04       Impact factor: 3.411

3.  Microsome- and hepatocyte-mediated mutagenicity of hydroxyurea and related aliphatic hydroxamic acids in V79 Chinese hamster cells.

Authors:  K Ziegler-Skylakakis; L R Schwarz; U Andrae
Journal:  Mutat Res       Date:  1985 Nov-Dec       Impact factor: 2.433

4.  Effect of inhibition of Helicobacter pylori urease activity by acetohydroxamic acid on serum gastrin in duodenal ulcer subjects.

Authors:  A M el Nujumi; C A Dorrian; R S Chittajallu; W D Neithercut; K E McColl
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

5.  Hydroxyurea: differential lethal effects on cultured mammalian cells during the cell cycle.

Authors:  W K Sinclair
Journal:  Science       Date:  1965-12-24       Impact factor: 47.728

6.  Quantitative microtiter cytotoxicity assay for Shigella toxin.

Authors:  M K Gentry; J M Dalrymple
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

7.  Characterization of urease from Campylobacter pylori.

Authors:  H L Mobley; M J Cortesia; L E Rosenthal; B D Jones
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948
  7 in total
  1 in total

1.  A small-molecular inhibitor against Proteus mirabilis urease to treat catheter-associated urinary tract infections.

Authors:  Scarlet Milo; Rachel A Heylen; John Glancy; George T Williams; Bethany L Patenall; Hollie J Hathaway; Naing T Thet; Sarah L Allinson; Maisem Laabei; A Toby A Jenkins
Journal:  Sci Rep       Date:  2021-02-12       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.